ResMed Inc. sees institutional investors adjust stakes

Two hedge funds altered their positions in ResMed Inc. (NYSE:RMD) during the first quarter. Entropy Technologies LP increased its holding by 105.3%, bringing its ownership to 37,619 shares valued at about $8.45 million. In contrast, Cumberland Partners Ltd reduced its stake by 54.8%, selling 11,500 shares and ending the period with 9,500 shares valued at roughly $2.13 million.

ResMed’s shares opened around $195.43, with a 50‑day moving average of $198.70 and a 200‑day average of $224.98. The company reported fourth‑quarter earnings of $2.86 per share, topping analysts’ expectations of $2.79, on revenue of $1.43 billion, up 10.8 % year‑over‑year. Institutional investors collectively own about 55 % of the stock.